Increased circulating suPAR and PAI-1 levels are correlated with increased risk of major adverse CVD events, including death and MI in advanced coronary artery disease, as well as the early phase of atherosclerosis [285,286,287,288]. Here, SERPINE1 is linked to atherosclerosis.